@prefix this: <
https://w3id.org/np/RAQtej8ruymQDRyohVoSiI9uCQa6AsNuN0qmaoGZkmHZ4
> .
@prefix sub: <
https://w3id.org/np/RAQtej8ruymQDRyohVoSiI9uCQa6AsNuN0qmaoGZkmHZ4/
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix dct: <
http://purl.org/dc/terms/
> .
@prefix nt: <
https://w3id.org/np/o/ntemplate/
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix orcid: <
https://orcid.org/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
sub:researchproject
dct:description
"Antimicrobial resistance is one of the major human health threats of this century. Therefore, the NACTAR-programme focuses on research into new resources for antibiotics and alternatives to antibiotics. Preclinical validation is also part of the research programme, so that the new antibiotics or alternative therapies become available and accessible for healthcare at a fair and affordable price. (https://www.nwo.nl/en/researchprogrammes/novel-antibacterial-compounds-and-therapies-antagonising-resistance-nactar)" ;
a
<
https://schema.org/ResearchProject
> ;
rdfs:label
"NACTAR programme" ;
rdfs:seeAlso
<
https://www.nwo.nl/en/researchprogrammes/novel-antibacterial-compounds-and-therapies-antagonising-resistance-nactar
> ;
<
https://schema.org/endDate
> "2023" ;
<
https://schema.org/funder
> <
https://ror.org/04jsz6e67
> ;
<
https://schema.org/startDate
> "2017" ;
<
https://w3id.org/fair/fip/terms/has-research-domain
> <
http://edamontology.org/topic_3370
> , <
http://purl.obolibrary.org/obo/NCIT_C16414
> , <
http://www.fairsharing.org/ontology/subject/SRAO_0000097
> ;
<
https://www.w3.org/TR/owl-ref/#sameAs-def
> "Project number 16439" .
}
sub:provenance
{
sub:assertion
prov:wasAttributedTo
orcid:0000-0003-3837-6137
, <
https://ror.org/027bh9e22
> .
}
sub:pubinfo
{
this:
dct:created
"2025-09-19T13:43:28.439Z"^^
xsd:dateTime
;
dct:creator
orcid:0000-0003-3837-6137
;
dct:license
<
https://creativecommons.org/licenses/by/4.0/
> ;
npx:hasNanopubType
<
https://schema.org/ResearchProject
> ;
npx:introduces
sub:researchproject
;
npx:wasCreatedAt
<
https://nanodash.knowledgepixels.com/
> ;
nt:wasCreatedFromProvenanceTemplate
<
https://w3id.org/np/RAW4qDSeYWgZwQDIPBOKlaCoSQiLZeavVCNsJMCcpU3kY
> ;
nt:wasCreatedFromPubinfoTemplate
<
https://w3id.org/np/RA0J4vUn_dekg-U1kK3AOEt02p9mT2WO03uGxLDec1jLw
> , <
https://w3id.org/np/RAukAcWHRDlkqxk7H2XNSegc1WnHI569INvNr-xdptDGI
> ;
nt:wasCreatedFromTemplate
<
https://w3id.org/np/RAxZ8oT8CuDFBHelrkt-f2jpkSPWHqUwbs10cAx8B5yck
> .
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEA0n6evU1FvEZTSki0U1ZZonP4fbkMNqtRoJc6a03a336t35TFlOuNj64m2syxUS52+RCaC2HsR2f4JH+MEtljAGiuOEqXa2kD/REWpS+eNMxKnm7cAP42cvwoMTZ2/VHSA/lfxcXjEpP5LanZNJKpZjafanbHiJiiJdRXkqh0Mc68YLCD7joKwCR+f9YRphtNJx4mmt0Ibm3niXPB5SpQ+1sd2IaW2EnMPoPMf5hwYz5pwBDe4KGB0zmfCxwH2Kb+DQsBTrjOVwhr5wKYYTNmR5w1P2MREbnomZTaD8OwhbI9SSyA1ZFfGO2K1brfKFr6mvkgRv1A+ltcF2fQwBo3ZQIDAQAB" ;
npx:hasSignature
"waUFURnuCppRhgn/DAgVp4jIYM//OcnMZbM6E3PvI0pEytdTvwNCDkKRhacxCRCrjAX3egVfpDUZouU2bNzl3zbGfSkXypllXepMT7ouLvmC4GEB1+yEGY1yPi7sQKLXuLbTvSZ2NO7/cyjUp3z50iJ9JFBKDgSuYtsawOR9t8GRITSYKYn4CMLz/g4Ghr+ulEP4oA9vc2eFVqWJccBe6VpuHPpMA+DZAMog5Xgbb/o9z3g32orwiuLLENTX4gTgXQ8I0NdtvK+2D9HiL38XRmn2L/QIHGl02Ofn3TnqnM5joaC/ouwiO0eMSp0gxbYKp+hdz5BnqoTMsCeGg46mlw==" ;
npx:hasSignatureTarget
this:
;
npx:signedBy
orcid:0000-0003-3837-6137
.
}